Abstract
A variety of radio-pharmaceuticals have been used to identify myocardial infarction. Most have been based on substances, such as fluorescein or tetracycline, that were known to concentrate in infarcted muscle and which were labelled with gamma-emitting radio-nuclides [21]. The observations of Shen and Jennings [22] indicating that calcium is deposited in crystalline or subcrystalline form in irreversibly damaged myocardial cells led Bonte and colleagues [23] to speculate that techne- tium-99m pyrophosphate (99mTc PYP) might prove suitable for infarct imaging. They reasoned that the PYP would complex with the calcium in the damaged cells. Their observations showed that the technique was a sensitive means of demonstrating damaged myocardium.
Keywords
- Mitral Valve Disease
- Transmural Infarction
- Inferior Myocardial Infarction
- Myocardial Contusion
- Ventricular Infarction
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Amiel, M., Maseri, A., Petitier, H., Vasile, N. (1984). Radio-Nuclide Explorations: Pyrophosphate Myocardial Imaging. In: Coronary Artery Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69604-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-69604-6_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69606-0
Online ISBN: 978-3-642-69604-6
eBook Packages: Springer Book Archive